Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00681876
What this trial is testing

Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hellenic Oncology Research Group 16
Testing effectiveness (Phase 2)Ended earlyNCT01198548
What this trial is testing

High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

Who this might be right for
Stage IV Colon CancerStage IV Rectal Cancer
Roswell Park Cancer Institute 10
Not applicableUnknownNCT01311050
What this trial is testing

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center 46
Testing effectiveness (Phase 2)UnknownNCT05659290
What this trial is testing

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Testing effectiveness (Phase 2)Study completedNCT00044343
What this trial is testing

GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin

Who this might be right for
Colorectal Cancer
GlaxoSmithKline 80
Early research (Phase 1)WithdrawnNCT02573220
What this trial is testing

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Who this might be right for
Stage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Chicago
Post-approval studies (Phase 4)Ended earlyNCT01468623
What this trial is testing

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

Who this might be right for
Colorectal Cancer, Metastatic
Myriad Genetic Laboratories, Inc. 51
Large-scale testing (Phase 3)Study completedNCT00457691
What this trial is testing

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Pfizer 768
Not applicableStudy completedNCT01266564
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 205
Testing effectiveness (Phase 2)Study completedNCT04554836
What this trial is testing

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the Rectum
TheraOp 6
Large-scale testing (Phase 3)Study completedNCT00003287
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 554
Testing effectiveness (Phase 2)Looking for participantsNCT06801665
What this trial is testing

FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis

Who this might be right for
Colorectal Cancer Liver Metastasis
Hua Jiang 30
Large-scale testing (Phase 3)Study completedNCT00252564
What this trial is testing

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
US Oncology Research 247
Testing effectiveness (Phase 2)Study completedNCT01640444
What this trial is testing

Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)

Who this might be right for
Colorectal Cancer Metastatic
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 240
Large-scale testing (Phase 3)Active Not RecruitingNCT03869892
What this trial is testing

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 856
Testing effectiveness (Phase 2)Looking for participantsNCT06763029
What this trial is testing

Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Fudan University 36
Testing effectiveness (Phase 2)Ended earlyNCT00314353
What this trial is testing

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Who this might be right for
Colorectal Neoplasms
NSABP Foundation Inc 7
Testing effectiveness (Phase 2)Ended earlyNCT01955629
What this trial is testing

Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337551
What this trial is testing

Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive

Who this might be right for
Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment
Guiying Wang 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation